On The Lancet editorial
On May 8, The Lancet published an editorial criticising the Narendra Modi government's response to India's second COVID-19 outbreak, which has been redefining the meaning of 'snafu'. A…
hydroxychloroquine
7 posts
Spray and pray – the COVID-19 version
Kiran Mazumdar-Shaw is the head of Biocon, a company headquartered in Bengaluru and which has repurposed a drug called itolizumab – already approved to help manage severe chronic psoriasis in differen…
India's missing research papers
If you're looking for a quantification (although you shouldn't) of the extent to which science is being conducted by press releases in India at the moment, consider the following list of studi…
A non-self-correcting science
While I'm all for a bit of triumphalism when some component of conventional publication vis-à-vis scientific research – like pre-publication anonymous peer review – fails, and fails publicly, I sp…
The costs of correction
I was slightly disappointed to read a report in the New York Times this morning. Entitled 'Two Huge COVID-19 Studies Are Retracted After Scientists Sound Alarms', it discussed the implications…
A caveat for peer-review
Now that more researchers are finding more holes in the study in The Lancet, which claimed hydroxychloroquine – far from being a saviour of people with COVID-19 – actually harms them, I wonder where t…
'Science alone triumphs': A skeptic annotates
An article entitled 'Science alone triumphs: Providing a true picture of the world, only science can help India against coronavirus', penned by a Jayant Sinha, appeared on the Times of India&#…